Drug Shortage Report for DOCETAXEL INJECTION

Last updated on 2017-10-05 History
Report ID 1688
Drug Identification Number 02412233
Brand name DOCETAXEL INJECTION
Common or Proper name DOCETAXEL
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) DOCETAXEL
Strength(s) 80MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 2.88ML
ATC code L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-02-29
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare